TY - JOUR AU - Malapelle, Umberto AU - Iaccarino, Antonino AU - Rossi, Antonio PY - 2018 TI - Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy JF - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1 Y2 - 2018 KW - N2 - Programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) represent key targets for specific monoclonal antibody inhibitors, such as pembrolizumab, nivolumab and atezolizumab, currently used in clinical practice for the management of metastatic non-small cell lung cancer (NSCLC) patients (1). UR - https://tlcr.amegroups.org/article/view/23598